Manfred Kaufmann
Impact in
- Cancer Research top 0.1%
- Breast Cancer Treatment Studies
- Cancer Genomics and Diagnostics
- Oncology top 0.2%
- HER2/EGFR in Cancer Research
- Cancer Treatment and Pharmacology
- Cancer Cells and Metastasis
Papers in
-
- Breast Cancer Treatment Studies 47
- Oncology 60
- HER2/EGFR in Cancer Research 28
- Cancer Treatment and Pharmacology 13
- Cancer-related Molecular Pathways 9
- Cancer Cells and Metastasis 8
- Co-authors
- Gϋnter von Minckwitz (47 shared papers)Sibylle Loibl (31 shared papers)Serban Dan Costa (15 shared papers)Jens‐Uwe Blohmer (16 shared papers)J. Hilfrich (14 shared papers)Holger Eidtmann (12 shared papers)Christian Jackisch (16 shared papers)Wolfgang EIERMANN (13 shared papers)
- Journals
- Journal of Clinical Oncology (16 papers)European Journal of Cancer (8 papers)Breast Cancer Research and Treatment (8 papers)Breast Care (8 papers)Breast Cancer Research (6 papers)
- Partner nations
- GermanyUnited StatesUnited Kingdom
In The Last Decade
Manfred Kaufmann
158 papers receiving 17.5k citations
Manfred Kaufmann's Hit Papers
Peers
Comparison fields: 5 of 155
- Cancer Research 7.1k
- Oncology 8.0k
- Radiology, Nuclear Medicine and Imaging 1.8k
- Pathology and Forensic Medicine 1.4k
- Genetics 2.0k
Countries citing papers authored by Manfred Kaufmann
This map shows the geographic impact of Manfred Kaufmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Manfred Kaufmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Manfred Kaufmann more than expected).
Fields of papers citing papers by Manfred Kaufmann
This network shows the impact of papers produced by Manfred Kaufmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Manfred Kaufmann. The network helps show where Manfred Kaufmann may publish in the future.
Co-authors
The 25 scholars most cited alongside Manfred Kaufmann, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 160 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Definition and Impact of Pathologic Complete Response on Prognosis After Neoadjuvant Chemotherapy in Various Intrinsic Breast Cancer Subtypes Hit paper breakdown → | 2012 | 2095 |
| 2 | 2-year follow-up of trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer: a randomised controlled trial Hit paper breakdown → | 2007 | 1251 |
| 3 | Switching of postmenopausal women with endocrine-responsive early breast cancer to anastrozole after 2 years' adjuvant tamoxifen: combined results of ABCSG trial 8 and ARNO 95 trial Hit paper breakdown → | 2005 | 713 |
| 4 | Reduction in New Metastases in Breast Cancer with Adjuvant Clodronate Treatment Hit paper breakdown → | 1998 | 679 |
| 5 | Meta-Analysis of Breast Cancer Outcomes in Adjuvant Trials of Aromatase Inhibitors Versus Tamoxifen Hit paper breakdown → | 2009 | 652 |
| 6 | Recommendations From an International Expert Panel on the Use of Neoadjuvant (Primary) Systemic Treatment of Operable Breast Cancer: An Update Hit paper breakdown → | 2006 | 597 |
| 7 | 2009 | 567 | |
| 8 | 2011 | 555 | |
| 9 | 2003 | 523 | |
| 10 | 2010 | 450 | |
| 11 | 2000 | 443 | |
| 12 | 2011 | 384 | |
| 13 | 2009 | 365 | |
| 14 | Lapatinib versus trastuzumab in combination with neoadjuvant anthracycline-taxane-based chemotherapy (GeparQuinto, GBG 44): a randomised phase 3 trial Hit paper breakdown → | 2012 | 359 |
| 15 | 2005 | 346 | |
| 16 | 2013 | 314 | |
| 17 | 2011 | 282 | |
| 18 | 2003 | 281 | |
| 19 | 2007 | 273 | |
| 20 | 2001 | 260 |
About Manfred Kaufmann
Manfred Kaufmann is a scholar working on Cancer Research, Oncology, Reproductive Medicine, Pathology and Forensic Medicine and Genetics, having authored 160 papers that have together received 18.1k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (47 papers), HER2/EGFR in Cancer Research (28 papers), Estrogen and related hormone effects (17 papers), Cancer Treatment and Pharmacology (13 papers), Breast Lesions and Carcinomas (12 papers), Cancer-related Molecular Pathways (9 papers), Cancer Cells and Metastasis (8 papers) and Endometriosis Research and Treatment (8 papers). The work is most often cited by research in Cancer Research (7.1k citations), Oncology (8.0k citations), Radiology, Nuclear Medicine and Imaging (1.8k citations), Pathology and Forensic Medicine (1.4k citations) and Genetics (2.0k citations). Manfred Kaufmann has collaborated with scholars based in Germany, United States and United Kingdom. Frequent co-authors include Gϋnter von Minckwitz, Sibylle Loibl, Serban Dan Costa, Jens‐Uwe Blohmer, J. Hilfrich, Holger Eidtmann, Christian Jackisch, Wolfgang EIERMANN, Michael Untch and Bernd Gerber. Their work appears in journals such as Journal of Clinical Oncology, European Journal of Cancer, Breast Cancer Research and Treatment, Breast Care and Breast Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.